ERBB2 and breast carcinoma: While some scholars advocate that elevated IL-8 is mainly detected in hormone receptor-negative and HER2-positive breast cancer cases [112,113], a complex interplay exists between ER expression and IL8 in BRCA cells [114,115,116].